Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cushing Syndrome I: Introduction01:26

Cushing Syndrome I: Introduction

Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Structure-based virtual screening, molecular dynamics and MM-PBSA/GBSA analysis for the identification of novel CDK6 inhibitors against prostate cancer.

In silico pharmacology·2026
Same author

Microbiome and metabolomics provide insights into the metamorphosis and settlement in the jellyfish Aurelia coerulea inhibited by Bacillus pacificus.

Marine pollution bulletin·2026
Same author

A Doubly Caged Bis(salicylamide)-Based Anion Transporter for Phototriggered Breast Cancer Therapy.

ACS omega·2026
Same author

Multiresponsive solvatochromic fluorophores as viscosity and polarity sensors in solid and liquid state: Lipid droplet sensing in live cell imaging.

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy·2026
Same author

Elucidating the phytoremediation potential of aquatic macrophytes for Cd, Cr, and Pb under varying pH and salinity.

International journal of phytoremediation·2026
Same author

Synthesis of acyl hydrazide derivatives of α-naphthalene acetic acid as COX-2 inhibitors: <i>in vitro</i> evaluation, molecular docking and DFT studies.

Future medicinal chemistry·2026

Related Experiment Video

Updated: Jun 21, 2026

Full-Endoscopic Surgery for Hypothalamic Hamartoma Resection
02:22

Full-Endoscopic Surgery for Hypothalamic Hamartoma Resection

Published on: April 12, 2024

Hoffmann's syndrome: a case report.

Waseem Qureshi1, Ghulam Hassan, Ghulam Qadir Khan

  • 1SMHS Hospital, Srinagar, Kashmir, India.

German Medical Science : GMS E-Journal
|August 14, 2009
PubMed
Summary

This case study highlights hypothyroidism with myxoedema, a rare condition causing muscle stiffness and pseudo hypertrophy. Early thyroxine treatment improved symptoms but not muscle mass.

Keywords:
hypothyroidismmyopathypseudohypertrophy

Related Experiment Videos

Last Updated: Jun 21, 2026

Full-Endoscopic Surgery for Hypothalamic Hamartoma Resection
02:22

Full-Endoscopic Surgery for Hypothalamic Hamartoma Resection

Published on: April 12, 2024

Area of Science:

  • Endocrinology
  • Neurology
  • Genetics

Background:

  • Hypothyroidism with myxoedema is a rare endocrine disorder.
  • It presents with characteristic symptoms including muscle stiffness and pseudo hypertrophy.
  • This condition can significantly impact quality of life.

Purpose of the Study:

  • To describe a case of hypothyroidism with myxoedema in a young male.
  • To detail the clinical presentation, diagnostic findings, and treatment response.
  • To review the existing literature on this rare syndrome.

Main Methods:

  • A case report of a 21-year-old male with characteristic symptoms.
  • Clinical examination, laboratory investigations (thyroid function, muscle enzymes), and response to treatment were assessed.
  • Literature review was conducted to contextualize the case.

Main Results:

  • The patient presented with hypothyroidism, myxoedema, muscle stiffness, pseudo hypertrophy, weakness, and delayed reflexes.
  • Investigations confirmed hypothyroidism with elevated muscle enzymes.
  • Thyroxine replacement therapy led to significant clinical and biochemical improvement within six months, though muscle mass reduction was minimal.

Conclusions:

  • Hypothyroidism with myxoedema is a treatable condition with appropriate hormone replacement.
  • While thyroxine therapy improves systemic symptoms, muscle hypertrophy may persist.
  • This case underscores the importance of recognizing and managing this rare syndrome.